Atlas Trials

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2

Clinical trial NCT00780286 · COMPLETED

Trial details

NCT number
NCT00780286
Sponsor
Procter and Gamble
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2008-10-01
Primary completion
2008-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.